1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsRapid Response Partnership Vehicle (RRPV) is sponsored by BARDA. A flexible partnership mechanism to support the rapid development of medical countermeasures for public health emergencies.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
* **Contract Opportunity Type:**Special Notice (Original) * **Original Published Date:**Apr 15, 2026 03:00 pm EDT * **Original Response Date:**May 13, 2026 01:00 pm EDT * **Inactive Policy:**15 days after response date * **Original Inactive Date:**May 28, 2026 * **Original Set Aside:**No Set aside used * **Product Service Code:** AN42 - HEALTH R&D SERVICES; HEALTH CARE - OTHER; APPLIED RESEARCH * 541714 - Research and Development in Biotechnology (except Nanobiotechnology) * **Place of Performance:** This solicitation summary is to notify all potential offerors of a Request for Project Proposals (RPP) issued through the Rapid Response Partnership Vehicle (RRPV) Consortium on behalf of the Biomedical Advanced Research and Development Authority (BARDA) entitiled "Rapid Antigen Production for Immunoassay Diagnostics (RAPID)".
Through the Rapid Antibody Production for Immunoassay Diagnostics (RAPID) RPP, BARDA seeks to support advanced research and development of rapid antibody and other protein-based molecular recognition reagent generation platforms to enable timely production of immunoassay-ready reagents for diagnostic use.
The objective is to establish flexible, end-to-end systems capable of generating high-performance binders against known and emerging biological threats, with the goal of significantly compressing development timelines from pathogen sequence to assay-ready reagents—ideally within weeks.
A Proposer’s Conference and Teaming Connect for the Rapid Antibody Production for Immunoassay Diagnostics (RAPID) RPP will take place virtually on Monday, April 27, 2026 from 11am-12pm EST. The full RPP, how to register for the Conference, and information on joining the consortium can be accessed through the RRPV website - www. rrpv.
org. * O’NEILL HOUSE OFFICE BUILDING * **May 28, 2026 11:55 pm EDT**Special Notice (Original)
According to the current listing, eligibility includes: Nonprofits, Universities, State/local governments, Small businesses, For-profit organizations. Confirm the full requirements in the official notice before applying.
Rapid Response Partnership Vehicle (RRPV) is funded by BARDA. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.